|
On May 22 2017 06:49 Fildun wrote: Yeah, US prizes suck, but I thought we were talking about innovation and businesses setting up projects that stimulate said innovation. I see a lot more of that in the US than in Europe. It's like how Nike makes a new pair of Jordans for maybe $5 and sells it for $100, the pharmaceutical industry is massively out gaining its expenses in the US because the government isn't willing to fight for its people. This is an area that needs to be normalized and have massive effects on the country without going "full on communism".
|
On May 22 2017 07:07 Gahlo wrote:Show nested quote +On May 22 2017 06:49 Fildun wrote: Yeah, US prizes suck, but I thought we were talking about innovation and businesses setting up projects that stimulate said innovation. I see a lot more of that in the US than in Europe. It's like how Nike makes a new pair of Jordans for maybe $5 and sells it for $100, the pharmaceutical industry is massively out gaining its expenses in the US because the government isn't willing to fight for its people. This is an area that needs to be normalized and have massive effects on the country without going "full on communism".
Most of this is because the corps selling the drugs just purchase it from the researchers rather than develop them. Because we have little enough funding for scientists that they need to sell their discoveries to continue.
|
On May 22 2017 07:40 PrinceXizor wrote:Show nested quote +On May 22 2017 07:07 Gahlo wrote:On May 22 2017 06:49 Fildun wrote: Yeah, US prizes suck, but I thought we were talking about innovation and businesses setting up projects that stimulate said innovation. I see a lot more of that in the US than in Europe. It's like how Nike makes a new pair of Jordans for maybe $5 and sells it for $100, the pharmaceutical industry is massively out gaining its expenses in the US because the government isn't willing to fight for its people. This is an area that needs to be normalized and have massive effects on the country without going "full on communism". Most of this is because the corps selling the drugs just purchase it from the researchers rather than develop them. Because we have little enough funding for scientists that they need to sell their discoveries to continue. What?
|
On May 22 2017 08:19 Gahlo wrote:Show nested quote +On May 22 2017 07:40 PrinceXizor wrote:On May 22 2017 07:07 Gahlo wrote:On May 22 2017 06:49 Fildun wrote: Yeah, US prizes suck, but I thought we were talking about innovation and businesses setting up projects that stimulate said innovation. I see a lot more of that in the US than in Europe. It's like how Nike makes a new pair of Jordans for maybe $5 and sells it for $100, the pharmaceutical industry is massively out gaining its expenses in the US because the government isn't willing to fight for its people. This is an area that needs to be normalized and have massive effects on the country without going "full on communism". Most of this is because the corps selling the drugs just purchase it from the researchers rather than develop them. Because we have little enough funding for scientists that they need to sell their discoveries to continue. What? A lot of pharma companies just purchase rights rather than develop new medicine on their own. and thus look at the drugs as solely an investment, they take their 80 million dollar rights and think "we have 2 years to recoup, we sell 100k units a year, charge 800 a unit".or insert real money amounts there.
So the people who produce the drugs sell the rights off in order to keep the research companies and groups alive. and the pharma corps that buy the rights don't have much relationship to those that develop the drugs.
With better funding to researchers, they dont have to sell rights to keep the doors open and the labs running.
|
On May 22 2017 08:28 PrinceXizor wrote:Show nested quote +On May 22 2017 08:19 Gahlo wrote:On May 22 2017 07:40 PrinceXizor wrote:On May 22 2017 07:07 Gahlo wrote:On May 22 2017 06:49 Fildun wrote: Yeah, US prizes suck, but I thought we were talking about innovation and businesses setting up projects that stimulate said innovation. I see a lot more of that in the US than in Europe. It's like how Nike makes a new pair of Jordans for maybe $5 and sells it for $100, the pharmaceutical industry is massively out gaining its expenses in the US because the government isn't willing to fight for its people. This is an area that needs to be normalized and have massive effects on the country without going "full on communism". Most of this is because the corps selling the drugs just purchase it from the researchers rather than develop them. Because we have little enough funding for scientists that they need to sell their discoveries to continue. What? A lot of pharma companies just purchase rights rather than develop new medicine on their own. and thus look at the drugs as solely an investment, they take their 80 million dollar rights and think "we have 2 years to recoup, we sell 100k units a year, charge 800 a unit".or insert real money amounts there. So the people who produce the drugs sell the rights off in order to keep the research companies and groups alive. and the pharma corps that buy the rights don't have much relationship to those that develop the drugs. With better funding to researchers, they dont have to sell rights to keep the doors open and the labs running. I don't see how that would keep costs down.
|
On May 22 2017 08:35 Gahlo wrote: I don't see how that would keep costs down.
Right now the pharma industry is a lot of investors and very little biochem or chem people. This is because investors can buy rights to a product from people desperate to sell, and flip the drug with a quick uptick in pricing. When people are less desperate they wont be selling to anyone who will buy, and some will be able to actually produce the medicine themselves, or open up the patent to the public.
If the Rights sell off isn't necessary to continue research, then former investment bankers aren't going to be the primary buyer of rights anymore, because they can't make a quick buck. Leading to a more stable market, and more stability will increase efficiency, and thus decrease pricing.
|
How does that stop the pharmaceutical companies from just paying more for the rights? How does that stop them, after they do, from setting the price high in the first place?
|
On May 22 2017 09:22 Gahlo wrote: How does that stop the pharmaceutical companies from just paying more for the rights? How does that stop them, after they do, from setting the price high in the first place? The companies that are driving costs up for consumers are just in the market for a quick turnaround. with higher initial costs they won't buy in as much. Internet companies can charge exorbitant amounts of money, but new ISPs don't pop up because of start up costs.
there is no single thing that will make healthcare cheap universally.
|
Wow... American medicine is expensive. Just compared danish vs american prices.
Quetiapine: 15$ vs 18$ ... what are you complaining about? Sertraline: 7$ vs 36$ ... hmm Lamotrigine: 15$ vs 86$ ... alright I see
drumroll for suspense....
Depakene: 13$ vs 494$ .... you guys are silly
Are locodoco pills just insanely expensive in america or is this a general trend? From what I could find there's only a few generic versions, so there'd be little to no competition to drive the price down?
Update on my comics: Going to visit a store that deals with vintage collectables later today. After finding this on google I'm pretty excited.
|
gl but i wouldnt expect 18k if i was you
|
|
|
Short Change Hero was had for karaoke, I approve (there's no decent version available if you want the lyrics on screen and no vocals though, smh).
Here's mine.
|
|
|
On May 22 2017 13:07 PrinceXizor wrote:Show nested quote +On May 22 2017 09:22 Gahlo wrote: How does that stop the pharmaceutical companies from just paying more for the rights? How does that stop them, after they do, from setting the price high in the first place? The companies that are driving costs up for consumers are just in the market for a quick turnaround. with higher initial costs they won't buy in as much. Internet companies can charge exorbitant amounts of money, but new ISPs don't pop up because of start up costs. there is no single thing that will make healthcare cheap universally. Companies are charging high prices because they can. That's why there was a big to do about EpiPens, which entered the market in 1987.
On May 22 2017 17:04 Jek wrote:Wow... American medicine is expensive. Just compared danish vs american prices. Quetiapine: 15$ vs 18$ ... what are you complaining about? Sertraline: 7$ vs 36$ ... hmm Lamotrigine: 15$ vs 86$ ... alright I see drumroll for suspense....Depakene: 13$ vs 494$ .... you guys are silly Are locodoco pills just insanely expensive in america or is this a general trend? From what I could find there's only a few generic versions, so there'd be little to no competition to drive the price down? Update on my comics: Going to visit a store that deals with vintage collectables later today. After finding this on google I'm pretty excited. There's a certain period of time(hazy memory says 7 years?) after a drug goes on the market over here before other companies are allowed to offer a generic.
|
That cover is amazing 6ah. I love well done covers.
One that springs to mind along the same lines as yours is + Show Spoiler +
I love these guys, they have some solid covers and their original stuff is also really well done.
Also may I recommend Weezer's cover of Paranoid Android. + Show Spoiler +
|
|
|
|
|
|
|
Alright, programmers of LL, let's take a vote. Single line If statements.
if(thing == true) doThing();
if(thing == true) doThing();
if(thing == true) { doThing(); }
if(thing == true) { doThing(); }
if(thing == true) { doThing(); }
Which is acceptable?
|
On May 23 2017 01:29 Requizen wrote:Alright, programmers of LL, let's take a vote. Single line If statements. if(thing == true) doThing(); if(thing == true) doThing(); if(thing == true) { doThing(); }if(thing == true) { doThing(); } if(thing == true) { doThing(); }Which is acceptable?
I'd say all but the 3rd one are totally fine; I prefer 2, 4, and 5. For me, I really like tab organization for spacing and legibility. But I'm also learning Python right now.
|
|
|
|
|
|